Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis with Inverse Gottron’s Sign

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2

References

  1. 1.

    Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5(CADM-140): a retrospective study. J Am Acad Dermatol. 2011; 65: 25-34.

    Article  Google Scholar 

  2. 2.

    Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol. 2018; 78: 776-85.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kosuke Ishizuka MD.

Ethics declarations

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ishizuka, K., Shikino, K. & Ikusaka, M. Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis with Inverse Gottron’s Sign. J GEN INTERN MED (2021). https://doi.org/10.1007/s11606-021-06748-y

Download citation